Probiodrug Provides further Insights into Science and Development of Glutaminyl Cyclase Inhibitor Development at 2013 Alzheimer’s Association International Conference

Probiodrug Sponsoring Symposium to Share Research Findings in the Role of Pyroglutamated Abeta in the Progression of Alzheimer’s Disease
Probiodrug Provides Update on Clinical Development of PQ912, its Most Advanced QC-inhibitor for Alzheimer’s Disease